Gossamer Bio Announces Participation in the 2019 Cantor Global Healthcare Conference

September 25, 2019 at 7:00 AM EDT

 SAN DIEGO--(BUSINESS WIRE)--Sep. 25, 2019-- Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that Sheila Gujrathi, M.D., Chief Executive Officer and Co-Founder, will present at the 2019 Cantor Global Healthcare Conference on Wednesday, October 2 at 7:45 a.m. ET.

A live webcast of the presentation will be available on the “Events and Presentations” page in the “Investors” section of the company’s website at https://ir.gossamerbio.com. A replay of the webcast will be archived on the company’s website for 90 days following the presentation.

 About Gossamer Bio 

 Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.

Source: Gossamer Bio, Inc.

 For Investors:
Argot Partners
Tel 212.600.1902
gossamerbio@argotpartners.com 

 For Media:
Argot Partners
David Rosen
Tel 212.600.1902
david.rosen@argotpartners.com